3/A

PRIMARY DOCUMENT

Company: FENNEC PHARMACEUTICALS INC.
Filed: September 13, 2017
Period of Report: September 11, 2017
Accession Number: 0001012975-17-000702

View Document ↗ View on SEC.gov ↗